Skip to main content
. 2024 Mar 25;8(3):344–379. doi: 10.7150/ntno.94987

Figure 11.

Figure 11

(I) A schematic depicting the oral nanotherapeutics of AG and the CO donor that work together to treat UC in a way that is both anti-inflammatory and productive in its resolution; (II) Targeting ability of AG/CORM-2@NP-Dex both in vitro and in vivo. Reproduced with the permission from ref. 125. Fig. 1, and Fig. 3. (ACS Publications).